Chromatographic systems for desalting and separating kinins: Application to trypsin-treated human plasma by Sampaio, Misako U. et al.
796
	
Conference Abstracts Vol. 16, No . 5
Aagiotenain (bovine) Asp-Arg-Val-Tyr-Val-Fas-Pro-Phe-IFis-Leu
Gallus Aallux (Angiotenain-F) Aep-Arg-Val-fyr-Val-His-Pro-Phe-Ser-Leu
Elaphe climocophora (Aagiotenain-S) X-Asp-Arg-Val-Tyr-Val-His-Pro-Phe-Tyr-Leu
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An analytical method is presented for the separation of Bradykinin (K-9),
Lys-Bradykinin (R-10), and Met-Lys-Bradykinin (K-11) by equilibrium chroma-
tography on SP-Sephadex, C-25 . The column (0.3 x 50 .0 cm) is operated at room
temperature under equilibrium conditions with 0.02 _M, Tria-HC1 buffer, pH 8 .10,
containing 0 .12 M NaCl . The kinina are identified on the basis of elution
volume and quantitated by bioassay with the isolated guinea pig ileum.
The system was applied to trypain-treated human plasma (1) . The ethanol
soluble fraction was desalted on AG 11-A 8 resin (0.9 x 200 cm) eluted with
H2O and chromatographed on SP-Sephadex at pH 8.1 . Bradykinin was the only
kinin detected in the effluent . However, the bradykinin was not completely
separated from potentiating peptides also released from plasma proteins by
trypain treatment (2) . Bradykinin was separated from the mixture of poten-
tiating peptides by chromatography on SP-Sephadex developed with 0.02 M Tris
HC1 buffer, pft 7 .7, containing 0 .08 _M NaCl . On this basis, plasma-derived
bradykinin potentiating peptides account for 30 to 40 percent of the "apparent"
kinin activity when kinin activity is assayed with the isolated guinea pig
ileum.
The pH 8.1 system has been used to purify commercially available synthetic
K-10 and K-11, which usually contain the lower kinin homologues as well as
oxidized forma of the sulfur in K-11 . Elution profiles of 5-20 micrograms of
synthetic kinins have been obtained by transmission measurements at 206 nm .
These systems can be used to measure the kinina released both as intermediates
and as limit products from kininogen and from plasma by treatment with proteo-
lytic enzymes .
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